AR042630A1 - Derivados de tetrahidroquinolina, composiciones farmaceuticas que los incluyen y su uso como medicamento. - Google Patents
Derivados de tetrahidroquinolina, composiciones farmaceuticas que los incluyen y su uso como medicamento.Info
- Publication number
- AR042630A1 AR042630A1 ARP030104729A ARP030104729A AR042630A1 AR 042630 A1 AR042630 A1 AR 042630A1 AR P030104729 A ARP030104729 A AR P030104729A AR P030104729 A ARP030104729 A AR P030104729A AR 042630 A1 AR042630 A1 AR 042630A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkoxy
- derivatives
- alkylamino
- pharmaceutical compositions
- tetrahydroquinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La presente se relaciona con composiciones farmacéuticas que comprenden estos derivados y con la utilización de estos derivados para regular la fertilidad. Reivindicación 1: Un derivado de tetrahidroquinolina, de acuerdo con la fórmula (1), o una sal farmacéuticamente aceptable de él, caracterizado porque R1 y R2 son H o Me; R3 es H, hidroxi, alcoxi (C1-4), (di)alquilamino(C1-4)-alcoxi(C2-4) o heterocicloalquil(C2-6)-alcoxi(C2-4); R4 es H, OH, alcoxi (C1-4) o R7; R5 es H, OH, alcoxi (C1-4) o R7; con la condición de que si R4 es H, R5 no es H, OH o alcoxi (C1-4) y de que si R5 es H, R4 no es H, OH o alcoxi (C1-4); R6 es heteroaril (C2-5), aril(C6), cicloalquil (C3-8), heterocicloalquil C2-6) o alquil (C1-6); R7 es amino, (di)alquilamino (C1-4), arilcarbonilamino(C6), arilcarboniloxi(C6), heteroarilcarbonilamino (C2-5), heteroarilcarboniloxi (C2-5), R8-alquilamino (C2-4), R8-alcoxi (C2-4), R9-metilamino o R9-metoxi; R8 es hidroxi, amino, alcoxi (C1-4), (di)alquilamino (C1-4), heterocicloalquil (C2-6), heterocicloalquilcarbonilamino (C2-6), (di)alquilaminocarbonilamino (C1-4), alcoxicarbonilamino (C1-4) y R9 es aminocarbonil, (di)alquilaminocarbonil (C1-4), heteroaril (C2-5) o aril(C6).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02102866 | 2002-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR042630A1 true AR042630A1 (es) | 2005-06-29 |
Family
ID=39311811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030104729A AR042630A1 (es) | 2002-12-20 | 2003-12-19 | Derivados de tetrahidroquinolina, composiciones farmaceuticas que los incluyen y su uso como medicamento. |
Country Status (18)
Country | Link |
---|---|
US (1) | US7858794B2 (es) |
EP (1) | EP1578726B1 (es) |
JP (1) | JP4545001B2 (es) |
AR (1) | AR042630A1 (es) |
AT (1) | ATE423771T1 (es) |
AU (1) | AU2003298363B2 (es) |
BR (1) | BR0317518A (es) |
CA (1) | CA2508952C (es) |
CL (1) | CL2003002685A1 (es) |
ES (1) | ES2321830T3 (es) |
NZ (1) | NZ540578A (es) |
PE (1) | PE20040928A1 (es) |
PL (1) | PL377318A1 (es) |
RS (1) | RS51293B (es) |
RU (1) | RU2328488C2 (es) |
TW (1) | TWI306855B (es) |
UA (1) | UA81442C2 (es) |
WO (1) | WO2004056780A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03011908A (es) * | 2001-07-02 | 2004-06-03 | Akzo Nobel Nv | Derivados de tetrahidroquinolina. |
TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
US7687623B2 (en) | 2005-05-12 | 2010-03-30 | Wyeth Llc | Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists |
US7678787B2 (en) | 2005-06-09 | 2010-03-16 | Wyeth | Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
RU2008126228A (ru) * | 2005-11-30 | 2010-01-10 | Астеллас Фарма Инк. (Jp) | 2-аминобензамидное производное |
WO2008071455A1 (en) * | 2006-12-15 | 2008-06-19 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
EP1956016A1 (en) * | 2006-12-15 | 2008-08-13 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
GB0705656D0 (en) * | 2007-03-23 | 2007-05-02 | Addex Pharmaceuticals Sa | Novel compounds E1 |
TW200918058A (en) * | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
US8071587B2 (en) * | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
TW201116531A (en) * | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
US11185569B2 (en) * | 2016-05-04 | 2021-11-30 | University Of Cincinnati | ActRIIB:Fc to treat infertility in females |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2686182A (en) * | 1950-12-07 | 1954-08-10 | Basf Ag | O-hydroxy-dihydro-quinoline carboxylic acids |
DE19975054I2 (de) | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
HUT78117A (hu) | 1994-12-22 | 1999-11-29 | Ligand Pharmaceuticals Incorporated | Szteroid receptor modulátor kinolin- és kondenzált kinolinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények |
DE69931975T2 (de) * | 1998-08-07 | 2006-10-05 | Applied Research Systems Ars Holding N.V. | FSH Mimetika zur Behandlung von Infertilität |
US6200963B1 (en) * | 1999-03-31 | 2001-03-13 | American Home Products Corporation | Aryl sulfonic acids as FSH antagonists |
MXPA03011908A (es) * | 2001-07-02 | 2004-06-03 | Akzo Nobel Nv | Derivados de tetrahidroquinolina. |
TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
TW592127U (en) * | 2003-05-19 | 2004-06-11 | Tatung Co | Network-type physiology monitoring device |
-
2003
- 2003-12-15 TW TW092135447A patent/TWI306855B/zh not_active IP Right Cessation
- 2003-12-16 RU RU2005122946/04A patent/RU2328488C2/ru not_active IP Right Cessation
- 2003-12-16 AU AU2003298363A patent/AU2003298363B2/en not_active Ceased
- 2003-12-16 AT AT03796105T patent/ATE423771T1/de not_active IP Right Cessation
- 2003-12-16 BR BR0317518-9A patent/BR0317518A/pt active Search and Examination
- 2003-12-16 RS YUP-2005/0457A patent/RS51293B/sr unknown
- 2003-12-16 PL PL377318A patent/PL377318A1/pl not_active Application Discontinuation
- 2003-12-16 WO PCT/EP2003/051025 patent/WO2004056780A2/en active Application Filing
- 2003-12-16 EP EP03796105A patent/EP1578726B1/en not_active Expired - Lifetime
- 2003-12-16 US US10/540,336 patent/US7858794B2/en not_active Expired - Lifetime
- 2003-12-16 UA UAA200505288A patent/UA81442C2/xx unknown
- 2003-12-16 NZ NZ540578A patent/NZ540578A/en not_active IP Right Cessation
- 2003-12-16 JP JP2004561499A patent/JP4545001B2/ja not_active Expired - Fee Related
- 2003-12-16 ES ES03796105T patent/ES2321830T3/es not_active Expired - Lifetime
- 2003-12-16 CA CA2508952A patent/CA2508952C/en not_active Expired - Lifetime
- 2003-12-18 CL CL200302685A patent/CL2003002685A1/es unknown
- 2003-12-19 AR ARP030104729A patent/AR042630A1/es unknown
-
2004
- 2004-01-05 PE PE2004000023A patent/PE20040928A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TWI306855B (en) | 2009-03-01 |
NZ540578A (en) | 2006-12-22 |
UA81442C2 (en) | 2008-01-10 |
CL2003002685A1 (es) | 2005-04-08 |
US20060142334A1 (en) | 2006-06-29 |
WO2004056780A2 (en) | 2004-07-08 |
PE20040928A1 (es) | 2004-12-25 |
EP1578726A2 (en) | 2005-09-28 |
TW200418800A (en) | 2004-10-01 |
ES2321830T3 (es) | 2009-06-12 |
JP2006512347A (ja) | 2006-04-13 |
CA2508952A1 (en) | 2004-07-08 |
AU2003298363B2 (en) | 2009-09-24 |
CA2508952C (en) | 2011-09-13 |
ATE423771T1 (de) | 2009-03-15 |
RU2005122946A (ru) | 2005-12-20 |
BR0317518A (pt) | 2005-11-16 |
AU2003298363A1 (en) | 2004-07-14 |
WO2004056780A3 (en) | 2004-08-05 |
PL377318A1 (pl) | 2006-01-23 |
EP1578726B1 (en) | 2009-02-25 |
RS20050457A (en) | 2007-08-03 |
US7858794B2 (en) | 2010-12-28 |
JP4545001B2 (ja) | 2010-09-15 |
RS51293B (sr) | 2010-12-31 |
RU2328488C2 (ru) | 2008-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR042630A1 (es) | Derivados de tetrahidroquinolina, composiciones farmaceuticas que los incluyen y su uso como medicamento. | |
AR042629A1 (es) | Derivados de tetrahidroquinolina, composiciones farmaceuticas que los incluyen y su uso como medicamento. | |
AR082826A2 (es) | Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos | |
TR199903149T2 (xx) | Vask�lar hasar verme ajanlar� olarak kol�inol t�revlerinin kullan�m�. | |
AR083849A1 (es) | Antagonistas de mdm2 de espiro-oxindol | |
AR034390A1 (es) | Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa | |
AR035557A1 (es) | Un metodo para el tratamiento de desordenes proliferativos de las celulas asociadas con una actividad alterada de la cinasa dependiente de las celulas, un derivado de 3-ureido-pirazol, un procedimiento para su preparacion y una composicion farmaceutica que comprende dicho derivado | |
AR040047A1 (es) | 1-(aminoalquil)-3-sulfonilazaindoles como ligandos de la 5-hidroxitriptamina-6 | |
NO20073357L (no) | 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien | |
CO6241190A2 (es) | Compuestos para inhibicion enzimatica | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
UY27368A1 (es) | Nuevos compuestos | |
AR030959A1 (es) | Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen | |
NO20062098L (no) | Faststofftilstandmontelukast | |
AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
NO20062905L (no) | Nye hydroksaminsyreestere og farmasoytisk anvendelse derav | |
BR0012697A (pt) | Inibidores da diferenciação de th2 | |
AR037534A1 (es) | Derivado de adamantano, su uso en la fabricacion de un medicamento para usar en terapia, composicion farmaceutica, proceso para la preparacion de dicho compuesto y dicha composicion y compuestos intermediarios | |
ECSP067111A (es) | Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica | |
AR029151A1 (es) | Una sal cuaternaria de piperidina, su uso, un proceso para su preparacion, y una composicion farmaceutica que la contiene | |
AR036248A1 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
MY135646A (en) | Indolyl derivatives | |
HRP20060023A2 (en) | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
AR116036A1 (es) | DERIVADOS DE NAFTIRIDINA COMO INHIBIDORES DE INTEGRINA avb6 | |
AR045090A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |